These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24642799)

  • 1. Renal involvement in antiphospholipid syndrome.
    Sciascia S; Cuadrado MJ; Khamashta M; Roccatello D
    Nat Rev Nephrol; 2014 May; 10(5):279-89. PubMed ID: 24642799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney disease in primary anti-phospholipid antibody syndrome.
    Gracia-Tello B; Isenberg D
    Rheumatology (Oxford); 2017 Jul; 56(7):1069-1080. PubMed ID: 27550302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal manifestations of the antiphospholipid syndrome.
    Piette JC; Cacoub P; Wechsler B
    Semin Arthritis Rheum; 1994 Jun; 23(6):357-66. PubMed ID: 7939722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal involvement in antiphospholipid syndrome.
    de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
    Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy.
    Tektonidou MG
    Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):131-40. PubMed ID: 19048414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological features of antiphospholipid nephropathy in patients with Systemic Lupus Erythematosus.
    Naseeb F; Arfaj AA; Hamdani A; Kfoury H; Parvez K; Mogairen SA
    J Coll Physicians Surg Pak; 2015 May; 25(5):332-6. PubMed ID: 26008657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Involvement in Antiphospholipid Syndrome.
    Turrent-Carriles A; Herrera-Félix JP; Amigo MC
    Front Immunol; 2018; 9():1008. PubMed ID: 29867982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
    Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus.
    Venturelli V; Abrantes AM; Rahman A; Isenberg DA
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI72-SI85. PubMed ID: 38320586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Kushnir VV; Shakhnova EA; Miroshnichenko NG; Serova AG; Nesterova SG
    Ter Arkh; 2007; 79(6):16-25. PubMed ID: 17684961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.
    Tektonidou MG
    Front Immunol; 2018; 9():1181. PubMed ID: 29904380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
    Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
    Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
    Horita S; Zoshima T; Hara S; Koichi M; Hirayama S; Suzuki K; Nakashima A; Kawano M
    CEN Case Rep; 2021 Aug; 10(3):409-413. PubMed ID: 33595828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and renal involvement.
    Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
    Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and treatment of APS renal involvement.
    Tektonidou MG
    Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.